Exmceuticals Inc
CNSX:EXM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Exmceuticals Inc
Capital Expenditures
Exmceuticals Inc
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
Exmceuticals Inc
CNSX:EXM
|
Capital Expenditures
-CA$1.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Capital Expenditures
-$407m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-3%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Capital Expenditures
-CA$8m
|
CAGR 3-Years
18%
|
CAGR 5-Years
49%
|
CAGR 10-Years
6%
|
|
|
Cronos Group Inc
TSX:CRON
|
Capital Expenditures
-$26.1m
|
CAGR 3-Years
-73%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-36%
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Capital Expenditures
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Capital Expenditures
-CA$33.7m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-34%
|
|
Exmceuticals Inc
Glance View
EXMceuticals, Inc. is a pharmaceutical biosciences company, which engages in producing therapeutic cannabis. The company is headquartered in Calgary, Alberta. The company went IPO on 2019-01-31. The firm operates through its geographic segments, which include Canada, Portugal, Uganda and Netherlands. The Company’s subsidiaries include EXMceuticals Inc., EXMceuticals Holdings B.V, EXMceuticals Portugal, LDA and EXMceuticals Portugal II, Unipessoal Lda.
See Also
What is Exmceuticals Inc's Capital Expenditures?
Capital Expenditures
-1.1m
CAD
Based on the financial report for Jun 30, 2020, Exmceuticals Inc's Capital Expenditures amounts to -1.1m CAD.
What is Exmceuticals Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 1Y
-35%
Over the last year, the Capital Expenditures growth was -35%.
